Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Norethindrone Acetate × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Breast 1

Conditions

Interventions

Rituximab 1210 Cyclophosphamide 1133 Vincristine 572 Doxorubicin 508 Etoposide 461 Prednisone 435 Cytarabine 416 fludarabine 410 Methotrexate 372 Dexamethasone 349 fludarabine phosphate 341 Lenalidomide 312 Filgrastim 301 Bendamustine Hydrochloride 240 Radiotherapy 236 venetoclax 227 ibrutinib 218 obinutuzumab 206 Melphalan 198 Peripheral Blood Stem Cell Transplantation 192 Granulocyte Colony-Stimulating Factor 178 Gemcitabine 172 Bortezomib 169 Busulfan 161 Whole-Body Irradiation 159 Mycophenolic Acid 146 Tacrolimus 127 Magnetic Resonance Spectroscopy 125 Ifosfamide 124 Calcium Dobesilate 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01160315 2015-10-30

Erasme-POF

Erasme University Hospital

Phase 2/3 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡